CD8A and head and neck squamous cell carcinoma: To validate these findings in clinical samples, we assessed M1 and M2 macrophage and CD8+ T cell populations in patient tissues from head and neck squamous cell carcinoma (Figure 8E; Figure S22, Supporting Information).